- Home
- NL vs PALI Comparison
NL vs PALI Comparison
Compare NL & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NL | PALI |
|---|---|---|
| Founded | 1891 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.0M | 240.2M |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NL | PALI |
|---|---|---|
| Price | $5.63 | $1.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 54.1K | ★ 2.9M |
| Earning Date | 03-09-2026 | 03-24-2026 |
| Dividend Yield | ★ 10.72% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $158,285,000.00 | $260,000.00 |
| Revenue This Year | $9.32 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 8.46 | ★ 1500.39 |
| 52 Week Low | $5.04 | $0.55 |
| 52 Week High | $9.27 | $2.64 |
Technical Indicators
Market Signals| Indicator | NL | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 38.88 | 58.26 |
| Support Level | $5.28 | $1.58 |
| Resistance Level | $5.82 | $2.14 |
| Average True Range (ATR) | 0.30 | 0.11 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 7.79 | 76.29 |
Price Performance
Historical ComparisonAbout NL NL Industries Inc.
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.